Tempus AI, Inc. - TEM Company Short-Term Debt

Public company logo of Tempus (TEM)

Tempus AI profits from the fusion of AI and genomics, offering sequencing and data to pharmaceutical giants. The current level of short-term liabilities confirms the financial dynamics, where 0.07 describes the current status of the metric. The sustainability of the business is supported by exclusive archives of clinical data, for which corporations pay, as well as the implementation of software for the automatic selection of targeted therapies for cancer patients.

Tempus AI, Inc (TEM): Current Liabilities from 06/15/2024 to 10/28/2026

TEM (Tempus): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Tempus AI, Inc|TEM - Average Forecast Price
- market capitalization data:
Market Value Tempus AI|TEM - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Tempus|TEM - Net Asset Value|Market Cap to Net Assets Ratio tempus.com|TEM - Company Total Assets
- debt and liquidity data:
Debt to Equity Tempus AI, Inc|TEM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Tempus AI|TEM - Aggregate Debt Obligations|Debts to Book Capitalization Tempus AI|TEM - Company Long-Term Debts|Company Short-Term Debts Tempus
Analysis of all company metrics:Tempus AI Inc (TEM)
Product sample of Tempus AI, Inc.

Investors are valuing Tempus AI, Inc (TEM) through a balance between expansion and financial stability. This indicator aggregates all liabilities maturing within one year, highlighting the risk of cash flow gaps. By analyzing the short-term debt portfolio, one can determine the company's reliance on external refinancing. For Tempus AI, Inc (TEM), moderate debt is critical during the aggressive collection of biodata and the scaling of AI libraries. An optimal borrowing level confirms the issuer's ability to develop predictive analytics without compromising solvency.

Competitors of Tempus AI, Inc (TEM)

QGEN (Qiagen) - Company Short-Term Debts|IONS: Short-Term Debt|RGEN (Repligen Corp.) - Company Short-Term Debt|RNA (Avidity Corp) - Company Current Liabilities|Company Short-Term Debt CRISPR Therapeutics AG CRSP|Current Liabilities genedx.com (WGS)|Company Current Liabilities RARE|Company Short-Term Debts BEAM (Beam Therapeutics Inc)|Company Short-Term Debt SRPT|TWST - Short-Term Debt Volume|Company Current Liabilities 10x Genomics, Inc. (TXG)|NTLA - Company Short-Term Loans and Borrowings|STOK: Company Short-Term Debts|BioLife Solutions Inc (BLFS) - Company Short-Term Debts|WVE: Company Short-Term Debts|Short-Term Debt Volume Maze Therapeutics Corp (MAZE)|Sionna Therapeutics Inc (SION) - Company Current Liabilities|Company Short-Term Loans and Borrowings primemedicine.com (PRME)|Company Short-Term Debts TSHA|uniQure NV - Short-Term Debt Volume|MeiraGTx PLC (MGTX) - Company Short-Term Debt|RGNX - Company Short-Term Indebtedness|SLDB (Solid Biosciences Inc.) - Company Short-Term Debts|Company Current Liabilities ocugen.com|PacBio (PACB) - Company Current Liabilities|Amount of Current Liabilities Benitec Biopharma Inc|Design Pharma - Company Short-Term Debts|Short-Term Debt RCKT (Rocket Corp)|4D Molecular Therapeutics - Company Short-Term Debt|Company Current Liabilities Lexeo Therapeutics Inc. LXEO|Korro Bio, Inc (KRRO) - Company Short-Term Debts|EDIT: Company Short-Term Indebtedness|Company Short-Term Debt Silence Therapeutics Inc.|ProQR Therapeutics (PRQR) - Company Short-Term Indebtedness|CDXS (Codexis Inc) - Company Short-Term Debts|Company Short-Term Debts sangamo.com (SGMO)|Company Current Liabilities Nautilus Biotechnology|Amount of Current Liabilities Metagenomi Inc. (MGX)|DTIL: Company Short-Term Debts|Generation Bio Co - Short-Term Debt|BOLD: Company Short-Term Debt|XCUR: Company Current Liabilities|Company Short-Term Debt imunon.com (IMNN)|Current Liabilities Phio Pharmaceuticals Corp.|MBIO (Mustang Bio Inc) - Company Current Liabilities|Company Short-Term Debts RNAZ|BNGO (Bionano Genomics, Inc.) - Company Short-Term Debt|Short-Term Debt Volume adnas.com APDN|Company Current Liabilities bluebird bio|Company Short-Term Loans and Borrowings ImmunoPrecise Antibodies Ltd IPA|Omega - Company Short-Term Debts|OMIC - Company Short-Term Debts|Regulus Therapeutics - Company Short-Term Debts|Short-Term Debt Volume syros.com|TBIO - Company Current Liabilities|Company Short-Term Loans and Borrowings TRACON Pharmaceuticals Inc.|UBX (Unity Bio) - Company Short-Term Debts